Itradam 100 Capsule contains Itraconazole 100 mg, a broad-spectrum triazole antifungal agent indicated for the treatment of various fungal infections. Itraconazole exerts its antifungal effect by inhibiting the cytochrome P450-dependent enzyme lanosterol 14-α-demethylase, which is essential for the synthesis of ergosterol, a critical component of fungal cell membranes. This disruption leads to increased membrane permeability and ultimately fungal cell death. Itradam 100 is effective against a wide range of pathogenic fungi, including dermatophytes, yeasts such as Candida species, and molds like Aspergillus species. It is commonly prescribed for conditions such as onychomycosis, blastomycosis, histoplasmosis, aspergillosis, and other systemic and superficial fungal infections. The capsule formulation allows for oral administration with good bioavailability when taken with food. Dosage and duration of therapy depend on the type and severity of infection, patient response, and clinical judgment. Itraconazole should be used with caution in patients with hepatic impairment or congestive heart failure. Potential adverse effects include gastrointestinal disturbances, hepatotoxicity, and drug interactions due to its inhibition of CYP3A4 enzymes. Regular monitoring of liver function tests and clinical status is recommended during therapy. Itradam 100 Capsule should be used under medical supervision to ensure safety and efficacy.